Skip to main content

Table 1 Patient demographics

From: Values of serum intestinal fatty acid-binding protein, fecal calprotectin, and fecal human β-defensin 2 for predicting necrotizing enterocolitis

 

NEC

Control

Χ2/t/U

p value

Number of infants, n

30

40

  

Bowel resected, n

12

   

Length of bowel resected, M (IQR), cm

17.5 (10–30)

   

Bowel resection region

    

Small bowel, n (%)

8 (66.7%)

   

Larger bowel, n (%)

2 (16.7%)

   

Small bowel + larger bowel, n (%)

2 (16.7%)

   

NEC Stage II, n (%)

18 (60%)

-

  

NEC Stage III, n (%)

12 (40%)

-

  

Sex, male, n (%)

20 (66.6%)

25 (62.5%)

0.130

0.719

Gestational age, x ± SD, w

29.18 ± 1.63

29.51 ± 1.46

0.893

0.375

Birth weight, x ± SD, g

1,275.50 ± 274.47

1,356.00 ± 270.28

−1.225

0.225

Twin, n (%)

8 (26.7%)

9 (22.5%)

0.162

0.687

Birth asphyxia, n (%)

7 (23.3%)

7 (17.5%)

0.365

0.546

Premature rupture of membranes, n (%)

11 (36.7%)

15 (37.5%)

0.005

0.947

Days of sampling, M (IQR), d

16.0 (12.3–22.0)

16.0 (14.0–21.0)

636.000

0.669

  1. d: day; g: gram; IQR: interquartile range; NEC: necrotizing enterocolitis; SD: standard deviation; w: week